Trials / Unknown
UnknownNCT01776684
Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis
Detection of Resistance Genes From Serially Collected Plasma DNA in Non-small Cell Lung Cancer Patients Harboring EGFR Activating Mutation Who Are Being Treated With EGFR TKIs
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To detect resistance gene from serially collected plasma DNA in non-small cell lung cancer harbouring EGFR activating mutation who are being treated with EGFR TKIs by using castPCR method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EGFR TKIs (gefitinib, erlotinib, afatinib, et al) |
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-05-01
- Completion
- 2015-05-01
- First posted
- 2013-01-28
- Last updated
- 2013-01-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01776684. Inclusion in this directory is not an endorsement.